USP15 is implicated in different cancer-associated mechanisms, e.g., regulating TGF-β–dependent oncogenesis in glioblastoma [6], as well as promoting breast and ovarian cancer progression by stabilizing ERα and p53 mutant, suggesting it as a potential cancer therapeutic target [10–12]. This evidence concerns the gene USP15 and cancer.